Create an account to read this article
You need to create an account to read this article.
Create Account Sign in
Diabetes and Endocrinology
Cardiology and CTVS
Medicine
Imeglimin, A Potential New Treatment Option As Add-On To Insulin Therapy In Type 2 Diabetes: TIMES 3 Trial
0 Comments
Post a comment
No comments yet. Be the first to comment!